Fig. 5.
Expansion of splenic TCR-Vβ6+ T cells in GVHD.
The splenic frequency of T CD4+ and CD8+ T cells, expressing specific TCR-Vβ chains was determined by flow cytometry using FITC-labeled anti–Vβ-TCR monoclonal antibody and anti–CD4-PE and anti–CD8-PerCP monoclonal antibodies. Results are presented as percentage of total CD4+ (solid bars) and CD8+ (empty bars) T cells in animals, suffering from GVHD (GVHD; n = 2), in healthy control BM recipients (co; n = 2), and in untreated donor (C3H)-type and host (AKR)-type mice. TCR-Vβ11+ and TCR-Vβ8.3+ T-cell frequencies were determined as controls. Results are shown from 1 of 3 representative, identically designed experiments.